Lipocine Inc

(NASDAQ:LPCN)

Latest On Lipocine Inc (LPCN):

Date/Time Type Description Signal Details
2023-05-16 16:00 ESTNewsLipocine stock dips after bridging study data of LPCN 1154 for postpartum depressionN/A
2023-05-11 07:42 ESTNewsLipocine GAAP EPS of -$0.04 misses by $0.01N/A
2023-03-10 10:25 ESTNewsLipocine GAAP EPS of -$0.13 in-line, revenue of $0.5M misses by $0.91MN/A
2022-11-10 02:31 ESTNewsLipocine GAAP EPS of -$0.03 in-lineN/A
2022-09-26 22:11 ESTNewsLipocine announces plans to focus on treating CNS disorders, shares rise ~5%N/A
2022-08-09 04:47 ESTNewsLipocine GAAP EPS of -$0.04 in-line, revenue of $0.5M beats by $0.24MN/A
2022-06-14 18:59 ESTNewsLipocine stock rises premarket after being granted two U.S. patentsN/A
2022-05-09 12:48 ESTNewsLipocine GAAP EPS of -$0.04 misses by $0.02N/A
2022-03-30 03:57 ESTNewsAntares wins full FDA approval for testosterone replacement therapyN/A
2022-03-10 02:03 ESTNewsLipocine GAAP EPS of -$0.01, revenue of $16.1MN/A
2022-02-03 13:55 ESTNewsLipocine announces FDA accepted the marketing application for TlandoN/A
2021-12-22 19:56 ESTNewsDosing underway in Lipocine's mid-stage LPCN 1148 study for liver cirrhosisN/A
2021-11-11 08:53 ESTNewsLipocine Is One To Watch Based On Possible FDA Approval Of TLANDO And NASH DataN/A
2021-11-04 12:10 ESTNewsLipocine shares jump 9% after FDA Fast Track status for LPCN 1144 NASH treatmentN/A
2021-10-27 21:32 ESTNewsWarning: LPCN is at high risk of performing badlyN/A
2021-10-18 17:20 ESTNewsLipocine shares rise after TLANDO licensing agreement with Antares PharmaN/A
2021-09-28 19:43 ESTNewsFDA affirms class 1 NDA resubmission for Lipocine's TlandoN/A
2021-08-25 20:22 ESTNewsLipocine discloses mid-stage data for NASH candidateN/A
2021-08-06 06:20 ESTNewsLipocine EPS misses by $0.03N/A
2021-07-21 15:06 ESTNewsLipocine competitor prevails in patent infringement lawsuit for JatenzoN/A
2021-07-21 14:54 ESTNewsLipocine soars 9% on FDA greenlight for Phase 2 LPCN 1154 study in postpartum depressionN/A
2021-07-21 14:48 ESTNewsCantor initiates Lipocine with an overweight rating, sees 121% upsideN/A
2021-07-21 14:30 ESTNewsLipocine enters settlement and license agreement with Clarus TherapeuticsN/A
2021-05-06 15:07 ESTNewsLipocine EPS beats by $0.01N/A
2021-03-12 08:03 ESTEarnings EstimateAn EPS average of $0.24 is estimated for the 2022 year.Buy
2021-03-12 08:03 ESTEarnings EstimateAn EPS average of -$0.06 is estimated for the quarter ending on June 30, 2021.N/A
2021-03-12 08:03 ESTFinancialsCompany financials have been released.Neutral
2021-03-05 01:04 ESTNewsLipocine shares up after LPCN 1144 preclinical study resultsN/A
2021-01-25 19:13 ESTNewsLipocine under pressure on launching underwritten public offeringN/A
2021-01-13 01:15 ESTNewsLipocine announces positive results from phase 2biopsy-confirmed NASH studyN/A
2021-01-06 16:05 ESTFinancialsCompany financials have been released.Neutral
2020-12-14 21:25 ESTNewsLipocine: Imminent Catalysts In NASH And Oral Testosterone Replacement Therapy Make For A Strong BuyN/A
2020-12-11 12:04 ESTAnalyst RatingThe Analyst Target Price has increased from $3 to $5.33.Buy
2020-12-09 20:58 ESTNewsFDA Ok's Lipocine's testosterone replacement therapy, tentativelyN/A
2020-11-26 20:43 ESTFinancialsCompany financials have been released.Neutral
2020-11-14 04:35 ESTFinancialsCompany financials have been released.Neutral
2020-11-12 04:30 ESTFinancialsCompany financials have been released.Neutral
2020-11-11 12:22 ESTEarnings EstimateAn EPS average of -$0.04 is estimated for the quarter ending on March 31, 2021.Buy
2020-11-10 18:47 ESTNewsLipocine EPS misses by $0.01N/A
2020-11-07 16:22 ESTFinancialsCompany financials have been released.Neutral
2020-11-06 12:53 ESTNewsLipocine: TLANDO Might Become A Potential TRT Option In Patients With COVID-19 InfectionN/A
2020-09-26 13:18 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 05:24 ESTFinancialsCompany financials have been released.Neutral
2020-08-29 05:11 ESTNewsLipocine under pressure on extended timeline for FDA review of Tlando applicationN/A
2020-08-22 03:47 ESTNewsSeeking Alpha Catalyst WatchN/A
2020-08-14 09:21 ESTFinancialsCompany financials have been released.Neutral
2020-08-08 01:10 ESTFinancialsCompany financials have been released.Neutral
2020-08-07 05:06 ESTAnalyst RatingThe Analyst Target Price has decreased from $3.67 to $3.Neutral
2020-07-31 01:32 ESTFinancialsCompany financials have been released.Neutral
2020-07-23 17:37 ESTFinancialsCompany financials have been released.Neutral

About Lipocine Inc (LPCN):

Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of metabolic and endocrine disorders. Its primary development programs are based on oral delivery solutions for poorly bioavailable drugs. The company has a portfolio of product candidates designed to produce pharmacokinetic characteristics and facilitate lower dosing requirements, bypass first-pass metabolism in certain cases, reduce side effects, and eliminate gastrointestinal interactions that limit bioavailability. Its lead product candidate is TLANDO, an oral testosterone replacement therapy. The company's pipeline candidates also include LPCN 1144, an oral prodrug of bioidentical testosterone that is in Phase II Clinical trial for the treatment of non-cirrhotic non-alcoholic steatohepatitis (NASH); TLANDO XR, an oral prodrug of testosterone for once daily dosing, which has completed Phase II clinical trial in hypogonadal men; LPCN 1148, an oral prodrug of bioidentical testosterone that has completed phase I clinical trial for the treatment of NASH cirrhosis; and LPCN 1107, an oral hydroxyprogesterone caproate product that has completed dose finding Phase II clinical trial for the prevention of recurrent preterm birth. The company is headquartered in Salt Lake City, Utah.

LPCN Quotes by TradingView

See Advanced Chart

General

  • Name Lipocine Inc
  • Symbol LPCN
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 11
  • Last Split Factor1:100
  • Last Split Date2013-07-25
  • Fiscal Year EndDecember
  • IPO Date2013-10-22
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryPharmaceuticals
  • Gic SubIndustryPharmaceuticals
  • Web URLhttp://www.lipocine.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 286.68
  • Price/Book (Most Recent Quarter) 10.99
  • Enterprise Value Revenue 441.02
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$0.24
  • Next Year EPS Estimate $0.23
  • Next Quarter EPS Estimate -$0.07
  • Return on Assets -50%
  • Return on Equity -194%
  • Earnings Per Share -$0.55
  • Revenue Per Share $0
  • Gross Profit -5053695
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 150.09 million
  • EBITDA -11983663
  • Analyst Target Price $5.33
  • Book Value Per Share $0.22
View More

Share Statistics

  • Shares Outstanding 88.29 million
  • Shares Float 86.12 million
  • % Held by Insiders 331%
  • % Held by Institutions 10.99%
  • Shares Short 3.96 million
  • Shares Short Prior Month 4.74 million
  • Short Ratio 0.68
  • Short % of Float 5%
  • Short % of Shares Outstanding 5%
View More

Technicals

  • Beta 0.53
  • 52 Week High $2.42
  • 52 Week Low $0.36
  • 50 Day Moving Average 1.72
  • 200 Day Moving Average 1.53
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Lipocine Inc (LPCN) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Lipocine Inc (LPCN) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-11$N/A-$0.06-$0.065.21%
2020-09-302020-11-10$N/A-$0.07-$0.06-16.67%
2020-06-302020-08-06$N/A-$0.13-$0.07-85.71%
2020-03-312020-05-07$N/A-$0.14-$0.08-75%
2019-12-312020-03-13$N/A-$0.10-$0.100%
2019-09-302019-11-12$164990-$0.12-$0.2142.86%
2019-06-302019-08-07$N/A-$0.14-$0.2133.33%
2019-03-312019-05-08$N/A-$0.14-$0.153.45%
2018-12-312019-03-06$428031-$0.15-$0.13-12.53%
2018-09-302018-11-07$N/A-$0.12-$0.1936.84%
2018-06-302018-08-07$-428031-$0.15-$0.2539.02%
2018-03-312018-05-07$428031-$0.13-$0.2138.82%
2017-12-312018-03-12$N/A-$0.25-$0.23-8.7%
2017-09-302017-11-08$N/A-$0.22-$0.233.3%
2017-06-302017-08-07$N/A-$0.31-$0.310%
2017-03-312017-05-08$N/A-$0.26-$0.3013.33%
2016-12-312017-03-06$N/A-$0.16-$0.2434.43%
2016-09-302016-11-08$N/A-$0.18-$0.2938.78%
2016-06-302016-08-09$N/A-$0.32-$0.3611.72%
2016-03-312016-05-09$N/A-$0.38-$0.33-15.15%
2015-12-312016-03-10$N/A-$0.27-$0.3318.18%
2015-09-302015-11-12$N/A-$0.35-$0.25-40%
2015-06-302015-08-11$N/A-$0.26-$0.20-30%
2015-03-312015-05-07$N/A-$0.23-$0.258%
2014-12-312015-03-11$N/A-$0.32-$0.27-18.52%
2014-09-302014-11-10$N/A-$0.32-$0.5541.82%
2014-06-302014-08-13$N/A-$0.55-$0.42-30.95%
2014-03-312014-05-14$N/A-$0.41-$0.410%
2013-12-312014-03-31$N/A-$0.30-$0.27-11.11%
2013-09-302013-11-27$N/A-$0.39
2013-06-302013-08-28$N/A-$0.09
2013-03-312013-03-31$N/A-$0.09
2012-12-312012-12-31$7.71 million-$0.14
2012-09-302012-09-30$N/A-$0.16
2012-06-302012-06-30$-7710000-$1.75

Lipocine Inc (LPCN) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Lipocine Inc (LPCN) Chart:

Lipocine Inc (LPCN) News:

Below you will find a list of latest news for Lipocine Inc (LPCN) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Lipocine Inc (LPCN) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Latest LPCN Trades:

Date Shares Price
Jun 13, 2022 7:31 PM EST3$0.8492
Jun 13, 2022 7:39 PM EST100$0.85
Jun 13, 2022 7:46 PM EST100$0.84
Jun 13, 2022 7:49 PM EST100$0.835
Jun 13, 2022 7:57 PM EST1$0.85

Lipocine Inc (LPCN) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1535955/000163859920000594/0001638599-20-000594-index.htm
2020-02-12SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1535955/000103738920000059/0001037389-20-000059-index.htm
2019-10-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000110465919055092/0001104659-19-055092-index.htm
2019-10-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000110465919055094/0001104659-19-055094-index.htm
2019-10-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000110465919056511/0001104659-19-056511-index.htm
2019-11-07424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1535955/000110465919060839/0001104659-19-060839-index.htm
2019-11-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000110465919061367/0001104659-19-061367-index.htm
2019-11-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000110465919061976/0001104659-19-061976-index.htm
2019-11-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1535955/000110465919062585/0001104659-19-062585-index.htm
2019-11-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000110465919062605/0001104659-19-062605-index.htm
2019-11-13424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1535955/000110465919063286/0001104659-19-063286-index.htm
2019-11-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000110465919063293/0001104659-19-063293-index.htm
2019-11-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000110465919063788/0001104659-19-063788-index.htm
2019-11-14424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1535955/000110465919064164/0001104659-19-064164-index.htm
2019-11-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000110465919064172/0001104659-19-064172-index.htm
2019-11-15424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1535955/000110465919064670/0001104659-19-064670-index.htm
2019-11-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000110465919065076/0001104659-19-065076-index.htm
2019-12-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000110465919076463/0001104659-19-076463-index.htm
2020-01-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000110465920002836/0001104659-20-002836-index.htm
2020-01-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000110465920003237/0001104659-20-003237-index.htm
2020-02-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000110465920011006/0001104659-20-011006-index.htm
2020-02-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000110465920016289/0001104659-20-016289-index.htm
2020-02-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000110465920024088/0001104659-20-024088-index.htm
2020-02-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000110465920024503/0001104659-20-024503-index.htm
2020-02-26424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1535955/000110465920025053/0001104659-20-025053-index.htm
2020-02-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000110465920025054/0001104659-20-025054-index.htm
2020-02-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000110465920026183/0001104659-20-026183-index.htm
2020-03-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000110465920028911/0001104659-20-028911-index.htm
2020-03-1310-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1535955/000110465920032764/0001104659-20-032764-index.htm
2020-03-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000110465920032766/0001104659-20-032766-index.htm
2020-03-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000110465920038554/0001104659-20-038554-index.htm
2020-04-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000110465920041546/0001104659-20-041546-index.htm
2020-04-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000110465920044865/0001104659-20-044865-index.htm
2020-04-10424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1535955/000110465920045542/0001104659-20-045542-index.htm
2020-04-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000110465920047925/0001104659-20-047925-index.htm
2020-04-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000110465920049014/0001104659-20-049014-index.htm
2020-04-28DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1535955/000110465920051968/0001104659-20-051968-index.htm
2020-05-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000110465920056552/0001104659-20-056552-index.htm
2020-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1535955/000110465920057762/0001104659-20-057762-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000110465920057765/0001104659-20-057765-index.htm
2020-05-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000110465920059149/0001104659-20-059149-index.htm
2020-05-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000110465920060470/0001104659-20-060470-index.htm
2020-05-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000110465920062094/0001104659-20-062094-index.htm
2020-06-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000110465920071991/0001104659-20-071991-index.htm
2020-07-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000110465920082920/0001104659-20-082920-index.htm
2020-07-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000110465920084655/0001104659-20-084655-index.htm
2020-07-30S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1535955/000110465920088369/0001104659-20-088369-index.htm
2020-07-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000110465920088699/0001104659-20-088699-index.htm
2020-08-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000110465920089327/0001104659-20-089327-index.htm
2020-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1535955/000110465920091145/0001104659-20-091145-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000110465920091147/0001104659-20-091147-index.htm
2020-08-06424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1535955/000110465920091148/0001104659-20-091148-index.htm
2020-08-21424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1535955/000110465920097634/0001104659-20-097634-index.htm
2020-08-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000110465920097968/0001104659-20-097968-index.htm
2020-08-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000110465920100155/0001104659-20-100155-index.htm
2020-09-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000110465920104609/0001104659-20-104609-index.htm
2020-09-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000110465920106757/0001104659-20-106757-index.htm
2020-09-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000110465920106761/0001104659-20-106761-index.htm
2020-10-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000110465920111983/0001104659-20-111983-index.htm
2020-10-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000110465920114131/0001104659-20-114131-index.htm
2020-10-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000110465920114712/0001104659-20-114712-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000110465920121590/0001104659-20-121590-index.htm
2020-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000110465920122166/0001104659-20-122166-index.htm
2019-05-22PX14A6GNotice of exempt solicitation submitted by non-managementhttps://www.sec.gov/Archives/edgar/data/1535955/000114036119009636/0001140361-19-009636-index.htm
2020-05-20PX14A6GNotice of exempt solicitation submitted by non-managementhttps://www.sec.gov/Archives/edgar/data/1535955/000114036120012025/0001140361-20-012025-index.htm
2018-03-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000114420418013983/0001144204-18-013983-index.htm
2018-03-1210-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1535955/000114420418014093/0001144204-18-014093-index.htm
2018-04-27DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1535955/000114420418022850/0001144204-18-022850-index.htm
2018-05-04DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1535955/000114420418025219/0001144204-18-025219-index.htm
2018-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1535955/000114420418025522/0001144204-18-025522-index.htm
2018-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000114420418025524/0001144204-18-025524-index.htm
2018-05-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000114420418026332/0001144204-18-026332-index.htm
2018-06-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000114420418033157/0001144204-18-033157-index.htm
2018-06-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000114420418034049/0001144204-18-034049-index.htm
2018-06-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000114420418036342/0001144204-18-036342-index.htm
2018-06-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000114420418036675/0001144204-18-036675-index.htm
2018-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1535955/000114420418042231/0001144204-18-042231-index.htm
2018-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000114420418042232/0001144204-18-042232-index.htm
2018-08-08S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1535955/000114420418042552/0001144204-18-042552-index.htm
2018-08-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000114420418045349/0001144204-18-045349-index.htm
2018-08-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000114420418046847/0001144204-18-046847-index.htm
2018-09-20424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1535955/000114420418050132/0001144204-18-050132-index.htm
2018-10-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000114420418051675/0001144204-18-051675-index.htm
2018-10-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000114420418053318/0001144204-18-053318-index.htm
2018-11-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000114420418056795/0001144204-18-056795-index.htm
2018-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000114420418057174/0001144204-18-057174-index.htm
2018-11-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1535955/000114420418057761/0001144204-18-057761-index.htm
2018-11-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000114420418057762/0001144204-18-057762-index.htm
2018-11-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000114420418058127/0001144204-18-058127-index.htm
2018-11-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000114420418058725/0001144204-18-058725-index.htm
2018-12-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000114420418065510/0001144204-18-065510-index.htm
2018-12-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000114420418065819/0001144204-18-065819-index.htm
2018-12-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000114420418066651/0001144204-18-066651-index.htm
2019-01-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000114420419000774/0001144204-19-000774-index.htm
2019-01-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000114420419001492/0001144204-19-001492-index.htm
2019-01-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000114420419001913/0001144204-19-001913-index.htm
2019-01-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000114420419002177/0001144204-19-002177-index.htm
2019-01-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000114420419002508/0001144204-19-002508-index.htm
2019-01-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000114420419002959/0001144204-19-002959-index.htm
2019-02-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000114420419007530/0001144204-19-007530-index.htm
2019-03-0610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1535955/000114420419012434/0001144204-19-012434-index.htm
2019-03-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000114420419012435/0001144204-19-012435-index.htm
2019-03-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000114420419012674/0001144204-19-012674-index.htm
2019-03-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000114420419013395/0001144204-19-013395-index.htm
2019-03-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000114420419014460/0001144204-19-014460-index.htm
2019-03-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000114420419015861/0001144204-19-015861-index.htm
2019-03-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000114420419016088/0001144204-19-016088-index.htm
2019-03-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000114420419016413/0001144204-19-016413-index.htm
2019-04-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000114420419017898/0001144204-19-017898-index.htm
2019-04-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000114420419019156/0001144204-19-019156-index.htm
2019-04-30DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1535955/000114420419022112/0001144204-19-022112-index.htm
2019-05-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000114420419022665/0001144204-19-022665-index.htm
2019-05-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1535955/000114420419024378/0001144204-19-024378-index.htm
2019-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000114420419024380/0001144204-19-024380-index.htm
2019-05-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000114420419025779/0001144204-19-025779-index.htm
2019-05-1510-Q/AQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1535955/000114420419026336/0001144204-19-026336-index.htm
2019-05-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000114420419028428/0001144204-19-028428-index.htm
2019-06-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000114420419030684/0001144204-19-030684-index.htm
2019-06-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000114420419032049/0001144204-19-032049-index.htm
2019-06-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000114420419032136/0001144204-19-032136-index.htm
2019-07-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000114420419035466/0001144204-19-035466-index.htm
2019-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1535955/000114420419038038/0001144204-19-038038-index.htm
2019-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000114420419038040/0001144204-19-038040-index.htm
2019-08-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000114420419041715/0001144204-19-041715-index.htm
2019-09-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000114420419045547/0001144204-19-045547-index.htm
2019-09-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000114420419045549/0001144204-19-045549-index.htm
2019-09-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000114420419046380/0001144204-19-046380-index.htm
2019-10-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1535955/000114420419046623/0001144204-19-046623-index.htm
2020-02-06SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1535955/000139382520000065/0001393825-20-000065-index.htm
2019-11-22SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1535955/000153561019000102/0001535610-19-000102-index.htm
2020-01-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1535955/000153561020000037/0001535610-20-000037-index.htm
2020-02-25SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1535955/000153561020000075/0001535610-20-000075-index.htm
2018-06-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1535955/000163859918000697/0001638599-18-000697-index.htm
2018-06-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1535955/000163859918000698/0001638599-18-000698-index.htm
2018-06-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1535955/000163859918000699/0001638599-18-000699-index.htm
2018-06-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1535955/000163859918000700/0001638599-18-000700-index.htm
2018-12-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1535955/000163859918001326/0001638599-18-001326-index.htm
2018-12-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1535955/000163859918001327/0001638599-18-001327-index.htm
2019-05-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1535955/000163859919000557/0001638599-19-000557-index.htm
2019-06-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1535955/000163859919000608/0001638599-19-000608-index.htm
2019-06-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1535955/000163859919000609/0001638599-19-000609-index.htm
2019-06-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1535955/000163859919000610/0001638599-19-000610-index.htm
2019-06-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1535955/000163859919000611/0001638599-19-000611-index.htm
2019-11-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1535955/000163859919000966/0001638599-19-000966-index.htm
2019-11-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1535955/000163859919000975/0001638599-19-000975-index.htm
2019-12-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1535955/000163859919001010/0001638599-19-001010-index.htm
2019-12-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1535955/000163859919001011/0001638599-19-001011-index.htm
2019-12-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1535955/000163859919001020/0001638599-19-001020-index.htm
2020-01-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1535955/000163859920000002/0001638599-20-000002-index.htm
2020-01-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1535955/000163859920000105/0001638599-20-000105-index.htm
2020-01-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1535955/000163859920000106/0001638599-20-000106-index.htm
2020-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1535955/000163859920000313/0001638599-20-000313-index.htm
2020-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1535955/000163859920000591/0001638599-20-000591-index.htm
2020-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1535955/000163859920000592/0001638599-20-000592-index.htm
2020-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1535955/000163859920000593/0001638599-20-000593-index.htm
2020-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1535955/000163859920000594/0001638599-20-000594-index.htm

Lipocine Inc (LPCN) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Lipocine Inc (LPCN). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 331%
Institutional Ownership: 1099%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-12-04MORGAN R BROWNEVP and Chief Financial OfficeSell17,250.000.417,075.9563,812.00https://www.sec.gov/Archives/edgar/data/1535955/000163859919001011/0001638599-19-001011-index.htm
2020-03-17John W. HiguchiDirectorBuy220,000.000.3269,542.00696,498.00https://www.sec.gov/Archives/edgar/data/1535955/000163859920000313/0001638599-20-000313-index.htm
2019-05-24Mahesh V. PatelPresident and CEOBuy4,527.001.587,152.66726,639.00https://www.sec.gov/Archives/edgar/data/1535955/000163859919000557/0001638599-19-000557-index.htm
2019-05-24Mahesh V. PatelPresident and CEOBuy2,500.001.593,975.00729,139.00https://www.sec.gov/Archives/edgar/data/1535955/000163859919000557/0001638599-19-000557-index.htm
2019-05-24Mahesh V. PatelPresident and CEOBuy473.001.60756.80729,612.00https://www.sec.gov/Archives/edgar/data/1535955/000163859919000557/0001638599-19-000557-index.htm
2019-05-24Mahesh V. PatelPresident and CEOBuy2,500.001.644,100.00732,112.00https://www.sec.gov/Archives/edgar/data/1535955/000163859919000557/0001638599-19-000557-index.htm
2019-11-18Mahesh V. PatelCEO and PresidentBuy4,931.000.401,971.91737,043.00https://www.sec.gov/Archives/edgar/data/1535955/000163859919000966/0001638599-19-000966-index.htm
2019-11-18Mahesh V. PatelCEO and PresidentBuy40,259.000.4016,103.60777,302.00https://www.sec.gov/Archives/edgar/data/1535955/000163859919000966/0001638599-19-000966-index.htm
2019-11-18Mahesh V. PatelCEO and PresidentBuy4,810.000.422,019.24782,112.00https://www.sec.gov/Archives/edgar/data/1535955/000163859919000966/0001638599-19-000966-index.htm
2019-11-26Mahesh V. PatelPresident and CEOBuy1,272.000.43542.51783,384.00https://www.sec.gov/Archives/edgar/data/1535955/000163859919000975/0001638599-19-000975-index.htm
2019-11-26Mahesh V. PatelPresident and CEOBuy700.000.43298.62784,084.00https://www.sec.gov/Archives/edgar/data/1535955/000163859919000975/0001638599-19-000975-index.htm
2019-11-26Mahesh V. PatelPresident and CEOBuy1,100.000.43469.70785,184.00https://www.sec.gov/Archives/edgar/data/1535955/000163859919000975/0001638599-19-000975-index.htm
2019-11-26Mahesh V. PatelPresident and CEOBuy21,928.000.439,385.18807,112.00https://www.sec.gov/Archives/edgar/data/1535955/000163859919000975/0001638599-19-000975-index.htm
2019-12-04MORGAN R BROWNEVP and Chief Financial OfficeBuy57,500.0081,062.00https://www.sec.gov/Archives/edgar/data/1535955/000163859919001011/0001638599-19-001011-index.htm
2019-12-04Mahesh V. PatelCEO and PresidentSell43,500.000.4117,835.00908,612.00https://www.sec.gov/Archives/edgar/data/1535955/000163859919001010/0001638599-19-001010-index.htm
2019-12-10Mahesh V. PatelPresident and CEOBuy25,000.000.409,975.00933,612.00https://www.sec.gov/Archives/edgar/data/1535955/000163859919001020/0001638599-19-001020-index.htm
2019-12-04Mahesh V. PatelCEO and PresidentBuy145,000.00952,112.00https://www.sec.gov/Archives/edgar/data/1535955/000163859919001010/0001638599-19-001010-index.htm
2019-12-31Mahesh V. PatelCEO and PresidentBuy40,000.000.3815,340.00973,612.00https://www.sec.gov/Archives/edgar/data/1535955/000163859920000002/0001638599-20-000002-index.htm